LUMO Labs, Utrecht Region and Utrecht Health Seed Fund are investing 900,000 euros in Cordys Analytics, says LUMO Labs in a press release. The company’s AI-powered software platform for electrocardiogram analysis (AI-ECG software) offers a new and innovative solution to detect heart disease earlier and more accurately. By harnessing the power of advanced deep-learning techniques, this software identifies subtle patterns and abnormalities in ECG data that traditional diagnostic methods often miss.
The startup is a Dutch healthtech spin-out from the University Medical Center Utrecht (UMCU). Their software supports healthcare professionals in making informed decisions and minimising hospitalizations and complications associated with untreated heart conditions. The vendor-agnostic software seamlessly connects various healthcare organisations and ECG devices, making it a versatile tool for healthcare professionals working in different clinical settings and regions across the globe.
Its cloud-based architecture provides operational benefits, such as real-time data analysis, remote accessibility and scalability. The proprietary interface makes it user-friendly.
Collaboration with UMCU
“We are thrilled to have these investors on board. By joining their networks, we are well positioned to further expand our software platform and make it essential for clinical use,” said Cordys Analytics CEO John van den Berg. “Through our research collaboration with the UMCU, we will develop and refine AI-ECG algorithms and software and integrate our diagnostic services into the workflow of doctors and other healthcare professionals.”